Haemophilus influenzae (2018 Data)
Antibiotic |
% Susceptible |
Antibiotic |
% Susceptible |
|
Ampicillin | +/- |
Imipenem | + |
|
Azithromycin | + |
Levofloxacin | + |
|
Aztreonam | + |
Meropenem | + |
|
Cefazolin | Moxifloxacin | +
|
||
Cefepime | + |
Nitrofurantoin | &
|
|
Ceftazidime | + |
Oxacillin/Naf | - |
|
Ceftriaxone | + |
Penicillin | - |
|
Cefuroxime | + |
Piperacillin | +/-
|
|
Ciprofloxacin | + |
Piperacillin/tazo | + |
|
Clarithromycin | + |
Ticarcillin/Clav | + |
|
Clindamycin | - |
Tobramycin | + |
|
Doxycycline | + |
TMP/SMX | +/- |
|
Erythromycin | +/- |
Unasyn/Aug | + |
|
Gentamicin | + |
Vancomycin | - |
|
Number of isolates tested: Sanford Guide data
Comments: Participating labs test only for presence of beta-lactamase.
For historical susceptibility data click here
Numeric data represent local susceptibility data.
(+) = usually effective or >60% susceptible; (+/-) = clinical trials lacking or 30-60% susceptible; (-) = not effective clinically or <30% susceptible - Adapted with permission from The Sanford Guide to Antimicrobial Therapy
(*) Local (non-Sanford Guide) opinion
(S) = synergistic with penicillin/ampicillin;
(&) nitrofurantoin only useful for lower tract urinary tract infections
(+) = usually effective or >60% susceptible; (+/-) = clinical trials lacking or 30-60% susceptible; (-) = not effective clinically or <30% susceptible - Adapted with permission from The Sanford Guide to Antimicrobial Therapy
(*) Local (non-Sanford Guide) opinion
(S) = synergistic with penicillin/ampicillin;
(&) nitrofurantoin only useful for lower tract urinary tract infections